{{Rsnum
|rsid=72991
|Chromosome=11
|position=121373007
|Orientation=minus
|GMAF=0.3255
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 45.5 | 38.4 | 16.1
| HCB | 74.5 | 23.4 | 2.2
| JPT | 62.5 | 32.1 | 5.4
| YRI | 11.6 | 41.8 | 46.6
| ASW | 19.6 | 55.4 | 25.0
| CHB | 74.5 | 23.4 | 2.2
| CHD | 71.3 | 25.9 | 2.8
| GIH | 60.0 | 28.0 | 12.0
| LWK | 9.4 | 39.6 | 50.9
| MEX | 71.4 | 25.0 | 3.6
| MKK | 14.3 | 52.6 | 33.1
| TSI | 55.9 | 41.2 | 2.9
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=22491018
|Trait=None
|Title=Genome-wide association analysis implicates the involvement of eight loci with response to tocilizumab for the treatment of rheumatoid arthritis.
|RiskAllele=
|Pval=5E-7
|OR=2.4500
|ORtxt=None
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}